Works matching IS 09024441 AND DT 2021 AND VI 107 AND IP 1
Results: 19
Predictors for and outcomes after bone marrow biopsy in Scandinavian patients with chronic immune thrombocytopenia.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 145, doi. 10.1111/ejh.13635
- By:
- Publication type:
- Article
"Ex‐vivo" T‐cell depletion in allogeneic hematopoietic stem cell transplantation: New clinical approaches for old challenges.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 38, doi. 10.1111/ejh.13636
- By:
- Publication type:
- Article
Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population‐based cohort study.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 137, doi. 10.1111/ejh.13633
- By:
- Publication type:
- Article
Translation, validation, and usability of the International Society on Thrombosis and Haemostasis Bleeding Assessment Tool (Self‐ISTH‐BAT).
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 104, doi. 10.1111/ejh.13625
- By:
- Publication type:
- Article
Healthcare resource utilisation and sickness absence in newly diagnosed multiple myeloma patients who did not undergo autologous stem cell transplantation: Trends in Sweden with the changing treatment landscape.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 92, doi. 10.1111/ejh.13623
- By:
- Publication type:
- Article
Clinicopathological factors and tumor microenvironment markers predicting watch‐and‐wait discontinuation in 82 patients with follicular lymphoma.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 157, doi. 10.1111/ejh.13637
- By:
- Publication type:
- Article
Soluble programmed cell death protein 1 (sPD‐1) and the soluble programmed cell death ligands 1 and 2 (sPD‐L1 and sPD‐L2) in lymphoid malignancies.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 81, doi. 10.1111/ejh.13621
- By:
- Publication type:
- Article
Association between red blood cell transfusion dependence and burden in patients with myelodysplastic syndromes: A systematic literature review and meta‐analysis.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 3, doi. 10.1111/ejh.13619
- By:
- Publication type:
- Article
A new reliable and highly specific monoclonal antibody to detect the C‐terminal region of silencer of cytokine signaling 1.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 74, doi. 10.1111/ejh.13620
- By:
- Publication type:
- Article
Congenital erythrocytosis.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 29, doi. 10.1111/ejh.13632
- By:
- Publication type:
- Article
Clinical predictors of SARS‐CoV‐2 neutralizing antibody titers in COVID‐19 convalescents: Implications for convalescent plasma donor recruitment.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 24, doi. 10.1111/ejh.13630
- By:
- Publication type:
- Article
Targeted deep next generation sequencing identifies potential somatic and germline variants for predisposition to familial Burkitt lymphoma.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 166, doi. 10.1111/ejh.13629
- By:
- Publication type:
- Article
Azacitidine for relapse of acute myeloid leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation, multicenter PALG analysis.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 129, doi. 10.1111/ejh.13628
- By:
- Publication type:
- Article
The management, outcome, and postpartum disease course of 41 pregnancies in 20 women with polycythemia vera.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 122, doi. 10.1111/ejh.13627
- By:
- Publication type:
- Article
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 111, doi. 10.1111/ejh.13626
- By:
- Publication type:
- Article
The impact of changed treatment patterns in multiple myeloma on health‐care utilisation and costs, myeloma complications, and survival: A population‐based comparison between two time periods in Denmark.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 63, doi. 10.1111/ejh.13615
- By:
- Publication type:
- Article
Long‐term tolerability of phosphodiesterase‐5 inhibitors in pulmonary hypertension of sickle cell disease.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 54, doi. 10.1111/ejh.13612
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 1, doi. 10.1111/ejh.13447
- Publication type:
- Article
Impact of hypoalbuminemia on the prognosis of relapsed/refractory B‐cell lymphoma treated with axicabtagene ciloleucel.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 48, doi. 10.1111/ejh.13609
- By:
- Publication type:
- Article